Drug ID:Drug127
Drug Name:hydrocortisone sodium succinate
CID:23694214
DrugBank ID:NULL
Modality:Small Molecule
Groups:NULL
US Approved:NULL
Other Approved:NULL
Identifier: NCT03110198
Molecular Formula:C25H33NaO8
Molecular Weight:484.5 g/mol
Isomeric SMILES:C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)[O-])O)C)O.[Na+]
Synonyms:Hydrocortisone sodium succinate; 125-04-2; A-hydroCort; Corlan; Solu-Cortef; Hidrokortizon; Nositrol; Rapicort; Cortop; Lycortin-S
Phase 0: 0
Phase 1: 0
Phase 2: 0
Phase 3: 0
Phase 4: 0
Description:NULL

Molecular Structure

2D Molecular Structure

Knowledge Graph

dtIDCIDCompound NameGene IDGene NameSpeciesPubMed IDsAction
dt1047 23694214 Hydrocortisone Sodium Succinate 2908 NR3C1 Homo sapiens (human) Glucocorticoid receptor agonist
dt1048 23694214 Hydrocortisone Sodium Succinate 367 AR Homo sapiens (human) None
dt1049 23694214 Hydrocortisone Sodium Succinate 2908 NR3C1 Homo sapiens (human) Agonist
dt1050 23694214 Hydrocortisone Sodium Succinate 4780 NFE2L2 Homo sapiens (human) None

  • No data available

Phase Distribution
Phase Description
  • Phase 0: Exploratory trials to assess drug behavior in humans
  • Phase 1: Safety trials to determine safe dosage range
  • Phase 2: Efficacy trials to evaluate therapeutic effects
  • Phase 3: Large-scale trials to confirm efficacy and safety
  • Phase 4: Post-marketing surveillance for long-term safety and efficacy

Trial IDTitlePhaseStatusSponsorIndicationsInterventions
NCT03110198 Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis PHASE4 UNKNOWN Xijing Hospital of Digestive Diseases Ulcerative Colitis, Unspecified DRUG: Mesalazine|DRUG: hydrocortisone sodium succ… Details

Disease IDDisease NameDefinitionCategoryRelated DrugsMechanism
No data available

Strategy IDTherapeutic StrategySynonymsRelated DrugsMechanism
No data available

No related literature

You can run management commands to establish drug-literature associations